677 related articles for article (PubMed ID: 19704167)
21. Viral features of lamivudine resistant hepatitis B genotypes A and D.
Zöllner B; Petersen J; Puchhammer-Stöckl E; Kletzmayr J; Sterneck M; Fischer L; Schröter M; Laufs R; Feucht HH
Hepatology; 2004 Jan; 39(1):42-50. PubMed ID: 14752821
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
Allen MI; Deslauriers M; Andrews CW; Tipples GA; Walters KA; Tyrrell DL; Brown N; Condreay LD
Hepatology; 1998 Jun; 27(6):1670-7. PubMed ID: 9620341
[TBL] [Abstract][Full Text] [Related]
23. Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.
Santantonio T; Fasano M; Durantel S; Barraud L; Heichen M; Guastadisegni A; Pastore G; Zoulim F
Antivir Ther; 2009; 14(4):557-65. PubMed ID: 19578241
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.
Natsuizaka M; Hige S; Ono Y; Ogawa K; Nakanishi M; Chuma M; Yoshida S; Asaka M
J Viral Hepat; 2005 Mar; 12(2):154-9. PubMed ID: 15720530
[TBL] [Abstract][Full Text] [Related]
25. Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis.
Marrone A; Zampino R; Karayannis P; Cirillo G; Cesaro G; Guerrera B; Ricciotti R; del Giudice EM; Utili R; Adinolfi LE; Ruggiero G
Aliment Pharmacol Ther; 2005 Oct; 22(8):707-14. PubMed ID: 16197491
[TBL] [Abstract][Full Text] [Related]
26. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.
Akarsu M; Sengonul A; Tankurt E; Sayiner AA; Topalak O; Akpinar H; Abacioglu YH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1783-8. PubMed ID: 17074014
[TBL] [Abstract][Full Text] [Related]
27. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
Kazim SN; Chauhan R; Das BC; Sarin SK
J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
[TBL] [Abstract][Full Text] [Related]
28. [Determination of the lamivudine-resistant mutants of hepatitis B virus].
Gervain J; Papp I; Csöndes M; Nemesánszky E; Rácz I; Ribiczey P; Telegdy L; Tornai I; Weisz G
Orv Hetil; 2003 Jun; 144(25):1251-6. PubMed ID: 12901182
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus genetic diversity.
Echevarría JM; Avellón A
J Med Virol; 2006; 78 Suppl 1():S36-42. PubMed ID: 16622876
[TBL] [Abstract][Full Text] [Related]
30. Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.
Hayashi K; Katano Y; Takeda Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Nakano I; Yano M; Goto H; Yoshioka K; Toyoda H; Kumada T
J Med Virol; 2007 Apr; 79(4):366-73. PubMed ID: 17311332
[TBL] [Abstract][Full Text] [Related]
31. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance.
Hsu CW; Yeh CT; Chang ML; Liaw YF
Gastroenterology; 2007 Feb; 132(2):543-50. PubMed ID: 17258721
[TBL] [Abstract][Full Text] [Related]
32. Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy.
Lai MW; Huang SF; Hsu CW; Chang MH; Liaw YF; Yeh CT
Antivir Ther; 2009; 14(2):249-61. PubMed ID: 19430100
[TBL] [Abstract][Full Text] [Related]
33. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy.
Yeh CT
Antivir Ther; 2010; 15(3 Pt B):471-5. PubMed ID: 20516567
[TBL] [Abstract][Full Text] [Related]
34. Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.
Shi M; Yang ZJ; Wang RS; Zhang H; Zhu YF; Xu YP; Lin QY; Jin LJ
Clin Chim Acta; 2006 Nov; 373(1-2):172-5. PubMed ID: 16814763
[TBL] [Abstract][Full Text] [Related]
35. Failure of the lamivudine-resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus secretion.
Vietheer PT; Netter HJ; Sozzi T; Bartholomeusz A
J Virol; 2005 May; 79(10):6570-3. PubMed ID: 15858045
[TBL] [Abstract][Full Text] [Related]
36. [Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients].
Wang C; Sun J; Chen JJ; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):729-30. PubMed ID: 18504191
[TBL] [Abstract][Full Text] [Related]
37. Lamivudine resistance in hepatitis B: mechanisms and clinical implications.
Fischer KP; Gutfreund KS; Tyrrell DL
Drug Resist Updat; 2001 Apr; 4(2):118-28. PubMed ID: 11512520
[TBL] [Abstract][Full Text] [Related]
38. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
Alvarado-Esquivel C; de la Ascensión Carrera-Gracia M; Conde-González CJ; Juárez-Figueroa L; Ruiz-Maya L; Aguilar-Benavides S; Torres-Valenzuela A; Sablon E
J Antimicrob Chemother; 2006 Feb; 57(2):221-3. PubMed ID: 16373428
[TBL] [Abstract][Full Text] [Related]
39. Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
Olivero A; Ciancio A; Abate ML; Gaia S; Smedile A; Rizzetto M
J Viral Hepat; 2006 Jun; 13(6):355-62. PubMed ID: 16842437
[TBL] [Abstract][Full Text] [Related]
40. Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B.
Chen JY; Wang LW; Sun XM; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):393-7. PubMed ID: 16109523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]